United Therapeutics Corporation (UTHR) Ownership
UTHR ownership summary
as of October 18, 2026- Institutions
- 100.0% of shares outstanding
- Insiders
- 2.00% of shares outstanding
- Shares outstanding
- 42.9M
- Float
- 39.2M shares available to trade
- Short interest
- 9.79% 3.6M shares short
- Days to cover
- 4.18 short interest up 28.4% vs prior month
- Institutions 100.01%
- Insiders 2.00%
UTHR top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 12.34% | 5.3M | $2.82B | −105,120 (−1.9%) | June 30, 2026 |
| 2 | venBio Select Advisor LLC | 6.48% | 2.8M | $1.48B | +147,777 (+5.6%) | June 30, 2026 |
| 3 | Vanguard Portfolio Management, LLC | 4.48% | 1.9M | $1.02B | −84,313 (−4.2%) | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 4.47% | 1.9M | $1.02B | −39,283 (−2.0%) | June 30, 2026 |
| 5 | State Street Corp | 4.43% | 1.9M | $1.01B | +54,101 (+2.9%) | June 30, 2026 |
| 6 | Renaissance Technologies Corp | 3.98% | 1.7M | $911.0M | −78,280 (−4.4%) | June 30, 2026 |
| 7 | Wellington Management Company LLP | 3.22% | 1.4M | $735.2M | −885,222 (−39.1%) | June 30, 2026 |
| 8 | Geode Capital Management, LLC | 2.32% | 997K | $531.3M | −236,431 (−19.2%) | June 30, 2026 |
| 9 | HHG PLC | 2.02% | 867K | $462.2M | +70,829 (+8.9%) | March 31, 2026 |
| 10 | Jupiter Topco LLC | 1.94% | 831K | $443.1M | +831,129 (0.0%) | June 30, 2026 |
| 11 | NORGES BANK | 1.62% | 695K | $370.4M | +92,562 (+15.4%) | June 30, 2026 |
| 12 | Genworth Financial Wealth Mgmt Inc | 1.46% | 624K | $332.7M | +8,018 (+1.3%) | June 30, 2026 |
| 13 | AQR Capital Management LLC | 1.27% | 546K | $291.1M | −280,224 (−33.9%) | June 30, 2026 |
| 14 | Dimensional Fund Advisors, Inc. | 1.23% | 528K | $281.4M | +15,165 (+3.0%) | June 30, 2026 |
| 15 | FMR Inc | 1.10% | 473K | $252.4M | −54,937 (−10.4%) | June 30, 2026 |
| 16 | Amvescap Plc. | 1.10% | 473K | $252.2M | −135,258 (−22.2%) | June 30, 2026 |
| 17 | Baillie Gifford & Co Limited. | 1.09% | 467K | $249.1M | +39,082 (+9.1%) | June 30, 2026 |
| 18 | Deerfield Management Co | 1.07% | 457K | $243.6M | — | June 30, 2026 |
| 19 | Morgan Stanley - Brokerage Accounts | 1.02% | 437K | $232.8M | +27,411 (+6.7%) | June 30, 2026 |
| 20 | Vestal Point Capital LP | 1.01% | 435K | $231.9M | +360,000 (+480.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 1.6M shares and 9 cut 1.9M.
UTHR top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Core S&P Mid-Cap ETF | 3.56% | 1.5M | $814.5M | −540 (−0.0%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 3.14% | 1.3M | $719.1M | −3,016 (−0.2%) | August 31, 2026 |
| 3 | Vanguard Small Cap Index | 2.25% | 965K | $514.7M | −11,257 (−1.2%) | September 30, 2026 |
| 4 | Vanguard Health Care Inv | 1.76% | 757K | $403.4M | −99,112 (−11.6%) | June 30, 2026 |
| 5 | iShares Biotechnology ETF | 0.75% | 323K | $172.4M | −2,448 (−0.8%) | September 30, 2026 |
| 6 | State Street® SPDR® S&P MIDCAP 400® ETF | 0.74% | 317K | $169.1M | +6,710 (+2.2%) | September 30, 2026 |
| 7 | Vanguard MStar Small Cap Value Index | 0.73% | 314K | $167.5M | +4,033 (+1.3%) | September 30, 2026 |
| 8 | Vanguard US Growth Investor | 0.71% | 304K | $162.1M | — | June 30, 2026 |
| 9 | Invesco S&P MidCap Quality ETF | 0.69% | 296K | $158.0M | +310 (+0.1%) | September 30, 2026 |
| 10 | State Street® SPDR® S&P® Biotech ETF | 0.68% | 293K | $156.5M | −5,600 (−1.9%) | September 30, 2026 |
| 11 | Invesco S&P MidCap Momentum ETF | 0.68% | 291K | $155.2M | — | September 30, 2026 |
| 12 | Vanguard MStar Small Cap Growth Indx Inv | 0.63% | 268K | $143.1M | −11,846 (−4.2%) | September 30, 2026 |
| 13 | iShares S&P Mid-Cap 400 Growth ETF | 0.58% | 248K | $132.0M | −264 (−0.1%) | September 30, 2026 |
| 14 | State Street SPDR Port S&P 400 Md CpETF | 0.53% | 227K | $120.9M | −320 (−0.1%) | September 30, 2026 |
| 15 | VictoryShares Free Cash Flow ETF | 0.52% | 223K | $118.9M | +150 (+0.1%) | September 30, 2026 |
| 16 | Fidelity Extended Market Index | 0.48% | 207K | $110.2M | −2,106 (−1.0%) | August 31, 2026 |
| 17 | FullerThaler Behavioral Sm-Cp Eq R6 | 0.48% | 204K | $109.0M | −62,000 (−23.3%) | June 30, 2026 |
| 18 | Franklin DynaTech Fund A | 0.47% | 200K | $106.6M | −25,000 (−11.1%) | August 31, 2026 |
| 19 | Swedbank Robur Aktiefond Pension | 0.46% | 197K | $105.0M | +75,375 (+62.0%) | September 30, 2026 |
| 20 | iShares MSCI USA Min Vol Factor ETF | 0.43% | 183K | $97.3M | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
UTHR insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-24 | Christopher Patusky | Sell | $569.00 | 2,910 | $1.7M |
| 2026-04-23 | James Edgemond | Sell | $572.21 | 9,636 | $5.5M |
| 2026-04-22 | James Edgemond | Sell | $575.85 | 364 | $209,609 |
| 2026-04-22 | Martine A Rothblatt | Sell | $576.56 | 9,500 | $5.5M |
| 2026-04-20 | James Edgemond | Sell | $577.86 | 10,000 | $5.8M |
| 2026-04-20 | Martine A Rothblatt | Sell | $577.83 | 9,500 | $5.5M |
| 2026-04-17 | Christopher Patusky | Sell | $578.88 | 1,000 | $578,880 |
| 2026-04-17 | Martine A Rothblatt | Sell | $586.66 | 9,500 | $5.6M |
| 2026-04-16 | James Edgemond | Sell | $577.18 | 10,000 | $5.8M |
| 2026-04-16 | Paul A Mahon | Sell | $576.82 | 8,300 | $4.8M |
| 2026-04-15 | Martine A Rothblatt | Sell | $580.36 | 9,500 | $5.5M |
| 2026-04-13 | James Edgemond | Sell | $574.88 | 10,000 | $5.7M |
| 2026-04-13 | Martine A Rothblatt | Sell | $574.86 | 9,500 | $5.5M |
| 2026-04-10 | Martine A Rothblatt | Sell | $569.28 | 9,500 | $5.4M |
| 2026-04-09 | James Edgemond | Sell | $577.89 | 10,000 | $5.8M |
| 2026-04-08 | Martine A Rothblatt | Sell | $580.45 | 9,500 | $5.5M |
| 2026-04-06 | James Edgemond | Sell | $558.40 | 10,000 | $5.6M |
| 2026-04-06 | Martine A Rothblatt | Sell | $558.41 | 9,500 | $5.3M |
| 2026-04-02 | James Edgemond | Sell | $561.50 | 10,000 | $5.6M |
| 2026-04-02 | Paul A Mahon | Sell | $565.87 | 8,300 | $4.7M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
UTHR shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns UTHR
Institutional investors own 100.0% of United Therapeutics's shares and insiders 2.00%. The largest holder is BlackRock Inc with 12.34% of the shares (5.3M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 9 reduced their stake in the latest filings. Short interest is 9.79% of the float, or 4.18 days of average trading volume. The share count fell 10.5% since 2014.
Related: UTHR analyst forecast, UTHR key metrics. See the UTHR stock overview for the latest quote and news.
UTHR ownership FAQ
Who owns the most United Therapeutics stock?
The largest shareholders of United Therapeutics are BlackRock Inc (12.34%), venBio Select Advisor LLC (6.48%), Vanguard Portfolio Management, LLC (4.48%), Vanguard Capital Management, LLC (4.47%), State Street Corp (4.43%).
What percentage of United Therapeutics is owned by institutions?
Institutions hold 100.0% of United Therapeutics's shares outstanding; insiders hold 2.00%.
Which funds own United Therapeutics?
The largest fund holders of United Therapeutics are iShares Core S&P Mid-Cap ETF (3.56%), Vanguard MStar Total Stk Mkt Idx Invest (3.14%), Vanguard Small Cap Index (2.25%), Vanguard Health Care Inv (1.76%), iShares Biotechnology ETF (0.75%).
What is United Therapeutics's short interest?
3.6M shares of United Therapeutics were sold short, 9.79% of the float; at the average daily volume it would take 4.18 days to cover.
Are insiders buying or selling United Therapeutics?
Of the latest 20 reported insider transactions in United Therapeutics (since April 2, 2026), 0 were purchases and 20 were sales.
How many shares of United Therapeutics are outstanding?
United Therapeutics has 42.9M shares outstanding, of which 39.2M are in the public float.